Yazar "Boz Er, Asiye Büşra" için listeleme
-
Integrin β3 reprogramming stemness in HER2-positive breast cancer cell lines
Boz Er, Asiye Büşra (MDPI, 2024)HER2-positive breast cancer, characterised by overexpressed HER2 levels, is associated with aggressive tumour behaviour and poor prognosis. Trastuzumab is a standard treatment; however, approximately 50% of patients develop ...